Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Randomized Trial: Lisinopril vs. Carvedilol vs. Placebo to Prevent Trastuzumab Cardiotoxicity in Patients with Breast Cancer

5 Jun, 2019 | 04:13h | UTC

Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer – Journal of the American College of Cardiology (link to abstract – $ for full-text)

“In patients with HER2-positive breast cancer treated with trastuzumab, both lisinopril and carvedilol prevented cardiotoxicity in patients receiving anthracyclines.”

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.